TM
NVAX icon

TigerOak Management’s Novavax NVAX Stock Holding History

TigerOak Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$100K Buy
10,641
+1
+0% +$9 0.03% 139
2026
Q1 		$86.6K Hold
10,640
– – 0.03% 126
2025
Q4 		$71.5K Hold
10,640
– – 0.02% 121
2025
Q3 		$92.2K Hold
10,640
– – 0.03% 117
2025
Q2 		$67K Hold
10,640
– – 0.02% 115
2025
Q1 		$68.2K Hold
10,640
– – 0.03% 107
2024
Q4 		$85.5K Buy
+10,640
New +$103K 0.03% 106

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

TigerOak Management's NVAX Position: Q2 2026 in Review

TigerOak Management increased its Novavax (NVAX) stake by 0.01% in Q2 2026, buying an estimated $9 and bringing the position to 10,641 shares worth $100K. The position accounts for 0.03% of the portfolio, ranked #139.

TigerOak Management first reported a position in NVAX in Q4 2024 and has held it in 7 quarters since. 268 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • TigerOak Management held 10,641 shares of Novavax worth $100K as of Q2 2026.
  • TigerOak Management bought 1 Novavax share in Q2 2026, an estimated $9.
  • Novavax made up 0.03% of TigerOak Management's portfolio in Q2 2026, its #139 holding.
  • TigerOak Management first reported a position in Novavax in Q4 2024 and has held it in 7 quarters since.
  • 268 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on TigerOak Management's 13F filing for Q2 2026, filed 11 Aug 2026.